Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised controlled trial of Skin Prick Testing
ISRCTN ISRCTN66284870
ClinicalTrials.gov identifier
Public title Randomised controlled trial of Skin Prick Testing
Scientific title
Acronym SPT
Serial number at source 06/039/SMI
Study hypothesis Does allergy assessment and appropriate advice in general practice enhance the care of patients with asthma and rhinitis and is it cost effective compared with routine medical care?
Lay summary Not provided at time of registration
Ethics approval Ethics approval received from the Multicentre Research Ethics Committee on the 26th May 2003 (ref: MREC/02/10/13).
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Asthma and rhinitis
Participants - inclusion criteria Patients with a working diagnosis of asthma and/or rhinoconjunctivitis
Participants - exclusion criteria 1. Less than 5 years or greater than 50 years
2. Terminal illness
3. Confusional state
4. History of anaphylaxis
5. Tested in the preceding two years
Anticipated start date 01/05/2006
Anticipated end date 01/05/2008
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 528 patients
Interventions Allergy intervention - structured allergy history and skin prick testing and appropriate advice on allergy avoidance versus routine medical care
Primary outcome measure(s) 1. Symptom scores (validated scale for asthma and rhinoconjunctivitis)
2. Health-related quality of life (using child or adult specific instruments)
Secondary outcome measure(s) 1. Patients' subjective assessment of symptomatic improvement
2. Change in patient management (introduction or withdrawal of allergen avoidance)
Sources of funding 1. Brighton and Sussex Medical School (UK) - originally held by from Southampton University
2. Alk-Abello Ltd (UK) (ref: D105 R107)
Trial website
Publications 1. 2009 results in http://www.ncbi.nlm.nih.gov/pubmed/19135237
Contact name Prof  Helen  Smith
  Address Brighton and Sussex Medical School
Mayfield House
University of Brighton
Falmer
  City/town Brighton
  Zip/Postcode BN1 9PH
  Country United Kingdom
  Tel +44 (0)1273 644563
  Email h.e.smith@bsms.ac.uk
Sponsor Brighton and Sussex University Hospitals NHS Trust (UK)
  Address Royal Sussex County Hospital
Eastern Road
  City/town Brighton
  Zip/Postcode BN2 5BE
  Country United Kingdom
  Tel +44 (0)1273 696955
  Email scott.harfield@bsuh.nhs.uk
  Sponsor website: http://www.bsuh.nhs.uk/
Date applied 25/04/2006
Last edited 08/02/2012
Date ISRCTN assigned 06/06/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central